Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX)

Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
6. 17
+0.36
+6.1962%
$
213.6M Market Cap
- P/E Ratio
- Div Yield
325,561 Volume
- Eps
$ 5.81
Previous Close
Investors:
Add Transaction
Day Range
5.8 6.28
Year Range
5.04 9.32
Want to track EPRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Eupraxia Pharmaceuticals Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
967,575 $7.23M $6.04M -$1.19M -16.45%
Christian Keedy
Christian Keedy Guardian Wealth Advisors LLC / Nc
10,500 $79,120 $66,622.5 -$12,497.5 -15.8%
Li Peng
Li Peng China Universal Asset Management Co. Ltd.
10,000 $72,400 $58,100 -$14,300 -19.75%
Taro Kuriyama
Taro Kuriyama Axq Capita LLP
15,760 $114,102 $98,263.6 -$15,838.4 -13.88%
Hui Fai Tam
Hui Fai Tam Caitong International Asset Management Co. Ltd.
1 $7 $6.24 -$0.76 -10.86%
Kevin Bresler
Kevin Bresler TD Waterhouse Canada Inc.
81,725 $551,909.29 $504,243.25 -$47,666.04 -8.64%
MA
Marie-Andree Alain Federation des caisses Desjardins du Quebec
9,091 $51,590 $56,727.84 $5,137.84 9.96%
Zachary Canonico
Zachary Canonico DIADEMA PARTNERS LP
40,000 $289,600 $262,000 -$27,600 -9.53%
SummitTX Capital LP
SummitTX Capital LP SummitTX Capital LP
327,997 $2.43M $2.2M -$225,101.78 -9.27%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
37,926 $274,584 $257,138.28 -$17,445.72 -6.35%